Objective. Extracellular matrix deposition is tightly controlled by a network of regulatory cytokines. Among them, interleukin-1 (IL-1) and transforming growth factor 1 (TGF1) have been shown to play antagonistic roles in tissue homeostasis. The purpose of this study was to determine the influence of IL-1 on TGF receptor type II (TGFRII) regulation and TGF1 responsiveness in human articular chondrocytes.Methods. TGF1-induced gene expression was analyzed through plasminogen activator inhibitor 1 and p3TP-Lux induction. Receptor-activated Smad (RSmad) phosphorylation, TGF receptors, and Smad expression were determined by Western blotting and real-time reverse transcription-polymerase chain reaction techniques. Signaling pathways were investigated using specific inhibitors, messenger RNA (mRNA) silencing, and expression vectors.Results. IL-1 down-regulated TGFRII expression at both the protein and mRNA levels and led to inhibition of the TGF1-induced gene expression and Smad2/3 phosphorylation. Moreover, IL-1 strongly stimulated the expression of inhibitory Smad7.TGFRII overexpression abolished the loss of TGF1 responsiveness induced by IL-1. The decrease in TGFRII required de novo protein synthesis and involved both the NF-B and JNK pathways.Conclusion. We demonstrate that IL-1 impairs TGF1 signaling through down-regulation of TGFRII, which is mediated by the p65/NF-B and activator protein 1/JNK pathways, and secondarily through the up-regulation of Smad7. These findings show that there is cross-talk in the signaling of 2 regulatory cytokines involved in inflammation.